Ctrlm Health News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ctrlm Health. Real-time updates on events, politics, business and more.

FDA approval of Zavzpret provides another critical tool to combat migraine

April 7, 2023

The FDA approval of Zavzpret, which Pfizer announced in March 2023, is good news for people living with migraine, as it becomes an important option to help combat this disease.

United States Allergan Abbvie Heather Biele Michigan State University College Of Human Medicine American Headache Society Disparities In Headache Advisory Council

Source: healio.com

More Positive Phase 3 Results 'Raise the Bar' for Migraine Drug

June 23, 2022

Secondary analyses of the phase 3 ADVANCE trial showed atogepant, a CGRP receptor antagonist, is superior to placebo across several migraine responder outcomes.

New York United States Richardb Lipton Elizabeth Loder Eli Lilly Allergan Abbvie

Source: medscape.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Ctrlm Health News Today

FDA approval of Zavzpret provides another critical tool to combat migraine

More Positive Phase 3 Results 'Raise the Bar' for Migraine Drug

Explore More Categories